Chris Thompson
Chris has been working on late stage biologics for the last twenty years both as a bench scientist and currently leading the CMC statistics group for biopharmaceutical development at AstraZeneca. He is also the co-chair of the ASA working group for Bayesian statistics in CMC.
Appearances
DateJanuary 29, 2025Prior knowledge is fundamental for the progression of science and critical for efficient product development and informed regulatory assessments of product safety and quality…Session Chairs
